‌

Tolemy Bio

AI-driven virtual cell platform for therapeutic development and manufacture

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Artificial Intelligence (AI)

Health technology

B2X

CEO

Founder

Caelan Anderson

Number of Employees (Ranges)

1 – 10

Email Address

Investors

Norrsken Evolve

Big Sur Ventures

Founded Date

2024

Total Funding Amount (USD)

1,700,000

Latest Funding Round Date

May 12, 2026

CTO

Caelan Anderson

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

1,700,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Tolemy Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.